Cargando…
Is (18)F-FDG PET/CT a real breakthrough imaging test in predicting the outcome of percutaneous ablation of metastases?
Autor principal: | Buchpiguel, Carlos Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Colégio Brasileiro de Radiologia e Diagnóstico por
Imagem
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472853/ https://www.ncbi.nlm.nih.gov/pubmed/31019353 http://dx.doi.org/10.1590/0100-3984.2019.52.2e1 |
Ejemplares similares
-
Complementary findings on (18)F-FDG PET/CT and
(18)F-NaF PET/CT in a patient with Erdheim-Chester
disease
por: Sabino, Daniela, et al.
Publicado: (2017) -
Is the (18)F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
por: Buchpiguel, Carlos Alberto
Publicado: (2017) -
(18)F-FDG PET/CT in the Follow-Up of Mucosal Leishmaniasis
por: Camargo, Raphael A., et al.
Publicado: (2018) -
Prevalence of exclusive lower extremity metastases at (18)F-NaF
PET/CT
por: Ordones, Monique Beraldo, et al.
Publicado: (2015) -
The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)